购物车
- 全部删除
- 您的购物车当前为空
BMS-1166 是 PD-1/PD-L1免疫检查点抑制剂。它促使 PD-L1 形成 PD-L1 同源二聚体,进而阻断其与 PD-1 的相互作用,其 IC50为 1.4 nM。它阻断了 PD-1/PD-L1 免疫检查点对 T 细胞活化的抑制作用。
BMS-1166 是 PD-1/PD-L1免疫检查点抑制剂。它促使 PD-L1 形成 PD-L1 同源二聚体,进而阻断其与 PD-1 的相互作用,其 IC50为 1.4 nM。它阻断了 PD-1/PD-L1 免疫检查点对 T 细胞活化的抑制作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 797 | 现货 | |
2 mg | ¥ 1,160 | 现货 | |
5 mg | ¥ 1,730 | 现货 | |
10 mg | ¥ 2,970 | 现货 | |
25 mg | ¥ 4,920 | 现货 | |
50 mg | ¥ 6,870 | 现货 | |
100 mg | ¥ 9,460 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,690 | 现货 |
产品描述 | BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor. |
靶点活性 | PD-1/PD-L1:1.4 nM |
体外活性 | BMS-1166可缓解可溶性PD-L1对T细胞受体介导的T淋巴细胞激活的抑制作用。此外,这些化合物在减轻细胞表面相关PD-L1的抑制效果方面也显示出有效性。 |
激酶实验 | Purified proteins in 10 mM Tris (pH 8.0) containing 20 mM NaCl, were concentrated to 5 mg/ml, mixed with the inhibitor in 1:3 molar ratio (protein:compound) and clarified by centrifugation at 15 000 × g for 10 min. Supernatant was used for screening using a sitting-drop vapor diffusion method. Diffraction-quality crystals were obtained at room temperature from 0.1 M Tris pH 8.5 containing 0.2 M magnesium chloride and 30% (w/v) PEG 4000 for the hPD-L1/BMS-1001 complex and from 0.01 M Tris pH 8.4 containing 0.28 M sodium chloride and 27% (w/v) PEG 4000 for hPD-L1/BMS-1166 complex. |
分子量 | 641.11 |
分子式 | C36H33ClN2O7 |
CAS No. | 1818314-88-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 125 mg/mL (194.97 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.